Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Change in Cash (2019 - 2025)

Historic Change in Cash for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$2.1 million.

  • Volitionrx's Change in Cash fell 25168.47% to -$2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year increase of 333.41%. This contributed to the annual value of -$17.5 million for FY2024, which is 27708.28% down from last year.
  • As of Q3 2025, Volitionrx's Change in Cash stood at -$2.1 million, which was down 25168.47% from -$344346.0 recorded in Q2 2025.
  • Volitionrx's Change in Cash's 5-year high stood at $13.6 million during Q1 2021, with a 5-year trough of -$9.0 million in Q1 2024.
  • In the last 5 years, Volitionrx's Change in Cash had a median value of -$2.1 million in 2025 and averaged -$1.0 million.
  • As far as peak fluctuations go, Volitionrx's Change in Cash skyrocketed by 37256.02% in 2021, and later crashed by 274202.38% in 2023.
  • Volitionrx's Change in Cash (Quarter) stood at -$2.3 million in 2021, then plummeted by 139.13% to -$5.5 million in 2022, then surged by 278.79% to $9.9 million in 2023, then crashed by 121.67% to -$2.1 million in 2024, then grew by 4.33% to -$2.1 million in 2025.
  • Its Change in Cash was -$2.1 million in Q3 2025, compared to -$344346.0 in Q2 2025 and -$664087.0 in Q1 2025.